Emergent BioSolutions announces up to C$140M in Canadian contracts

Emergent BioSolutions (EBS) announced a series of new contracts and a contract modification with the Public Health Agency of Canada and the Department of National Defence to deliver critical medical countermeasures to support Canada’s biological threat preparedness and response infrastructure. “We are proud to continue our longstanding collaboration with the Public Health Agency of Canada and the Department of National Defence as they implement a forward looking, strategic preparedness framework, serving as a model of best practices in health preparedness,” said Chris Sinclair, VP and head of global preparedness at Emergent. The multiyear agreements, valued at up to approximately C$140 million, build upon over a decade of collaboration between Emergent and Canada. Emergent will receive more than C$35M in orders in 2026.